Global Cell Therapy Technologies Market Size to Exceed USD 31.84 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Cell Therapy Technologies Market Size Expected to Grow from USD 6.22 Billion in 2023 to USD 31.84 Billion by 2033, at a CAGR of 17.74% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Cell Therapy Technologies Market Size, Share, and COVID-19 Impact Analysis, By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Cell therapy technologies market is the sector aimed at the production, fabrication, and commercialization of technology, equipment, and instruments involved in cell-based treatments. Such technologies aid in processing, growing, altering, and delivering therapeutic cells for cancer treatment, autoimmune disease, neurological disease, and regenerative medicine applications. Moreover, the cell therapy technologies market is driven by growing investments in regenerative medicine and the escalating incidence of chronic conditions such as cancer and autoimmune diseases. Breakthroughs in bioprocessing, gene editing, and stem cell research drive therapeutic value. The demand for personalized medicine, automation of cell processing, and better cryopreservation methods further stimulates market growth. Furthermore, increased clinical trials and regulatory approvals of CAR-T and stem cell therapies drive adoption. However, high expense, sophisticated manufacturing, and rigorous regulatory requirements limit market growth. Limited scalability, ethical issues, and problems with cell preservation and transport also inhibit the general acceptance of cell therapy technologies.
The instruments segment accounted for the largest share of the global cell therapy technologies market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of product, the global cell therapy technologies market is divided into raw materials and instruments. Among these, the instruments segment accounted for the largest share of the global cell therapy Technologies market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of their primary function in processing, growth, and preservation in cells. Specialized bioreactors, separation systems, and cryopreservation devices play key roles in enabling the effective development of cell therapies. Increasing technological advancements and automation further boost market demand for sophisticated instruments.
The expansion segment accounted for a substantial share of the global cell therapy technologies market in 2023 and is anticipated to grow at a rapid pace during the projected period.
On the basis of the workflow, the global cell therapy technologies market is divided into separation, and expansion. Among these, the expansion segment accounted for a substantial share of the global Cell Therapy Technologies market in 2023 and is anticipated to grow at a rapid pace during the projected period. This is because of its key function to expand therapeutic cell counts for the purposes of efficacious treatment. Growing demand for stem cell and CAR-T cell therapies, process developments in bioreactors, and automation in cell culture all further propel dominance by the expansion segment.
The T-cells segment accounted for the largest share of the global cell therapy technologies market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of cell type, the global cell therapy technologies market is divided into T-cells, and stem cells. Among these, the T-cells segment accounted for the largest share of the global cell therapy technologies market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of the increasing use of CAR-T cell therapies for cancer treatment. Rising FDA approvals, progress in immunotherapy, and expanding clinical studies on T-cell use in autoimmune diseases and infectious disorders also fuel their market dominance.
North America is projected to hold the largest share of the global cell therapy technologies market over the projected period.
North America is projected to hold the largest share of the global cell therapy technologies market over the projected period. This is powered by robust investments in biotech, sophisticated healthcare infrastructure, and a high rate of clinical trials. The United States is ahead in cell therapy research, underpinned by leading biotech companies, regulatory clearances, and growing uptake of regenerative medicine for cancer and autoimmune disease treatment.
Europe is expected to grow at the fastest CAGR of the global cell therapy technologies market during the projected period. This is sustained by rising government support, robust biotech research, and increasing use of regenerative medicine. Germany, the U.K., and France are at the forefront of clinical trials and new cell-based treatments. Stem cell advances and supportive regulations further boost regional market growth.
Company Profiling
Major vendors in the global cell therapy technologies market are BD, Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group, Danaher Corporation, Sartorius AG, Promega, Miltenyi Biotec, Shimadzu, CellPort Software, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In December 2024, BioCentriq invested USD 12 million in a new Princeton, NJ-based cell therapy manufacturing plant that also serves as its headquarters. The expansion will enhance its cell therapy development and production capacity.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global cell therapy technologies market based on the below-mentioned segments:
Global Cell Therapy Technologies Market, By Product
- Raw Materials
- Instruments
Global Cell Therapy Technologies Market, By Workflow
Global Cell Therapy Technologies Market, By Cell Type
Global Cell Therapy Technologies Market, By Regional
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa